Effect of rehabilitation and botulinum toxin injection on gait in chronic stroke patients: a randomized controlled study.

Authors

  • Nicolas Roche
  • Raphaël Zory
  • Antoine Sauthier
  • Celine Bonnyaud
  • Didier Pradon
  • Djamel Bensmail

DOI:

https://doi.org/10.2340/16501977-1887

Keywords:

stroke, hemiplegia, botulinum toxin injection, self-rehabilitation programme, gait, functional activities

Abstract

BACKGROUND: Botulinum toxin injections are used to treat spasticity in stroke. Although this treatment is effective on muscle tone, its effect on functional gait-related activities remains uncertain. OBJECTIVE: The aim of this randomized controlled trial was to determine the effect of a self-rehabilitation programme as an adjunct to botulinum toxin injections on gait-related activities in patients with chronic hemiparesis. METHODS: Thirty-five outpatients were included. Each patient was randomized to 1 of 2 groups: botulinum toxin + standardized self-rehabilitation programme (R group, n = 19) or botulinum toxin alone (C group, n = 16). Each patient was evaluated with the following tests before botulinum toxin injections and one month afterwards: 10-m timed walk, Timed Up and Go, distance covered in 6 min over an ecological circuit, and the stair test. RESULTS: There were significant improvements in the R group compared with the C group: maximal gait speed improved by 8% (p = 0.003)

Downloads

Download data is not yet available.

Downloads

Published

2014-08-27

How to Cite

Roche, N., Zory, R., Sauthier, A., Bonnyaud, C., Pradon, D., & Bensmail, D. (2014). Effect of rehabilitation and botulinum toxin injection on gait in chronic stroke patients: a randomized controlled study. Journal of Rehabilitation Medicine, 47(1), 31–37. https://doi.org/10.2340/16501977-1887

Issue

Vol. 47 No. 1 (2015)

Section

Original Report

License

All digitalized JRM contents is available freely online. The Foundation for Rehabilitation Medicine owns the copyright for all material published until volume 40 (2008), as from volume 41 (2009) authors retain copyright to their work and as from volume 49 (2017) the journal has been published Open Access, under CC-BY-NC licences (unless otherwise specified). The CC-BY-NC licenses allow third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
From 2024, articles are published under the CC-BY licence. This license permits sharing, adapting, and using the material for any purpose, including commercial use, with the condition of providing full attribution to the original publication.

Crossref
Scopus
Google Scholar
Europe PMC